Literature DB >> 7653257

Mechanisms of hearing loss in acoustic neuroma: an otoacoustic emission study.

D K Prasher1, T Tun, G B Brookes, L M Luxon.   

Abstract

Evoked otoacoustic emissions (EOAE) are active mechanical responses from the cochlea which provide information about the integrity of the preneural cochlear receptor mechanisms. It may be hypothesised, therefore, that if a hearing impairment is neural in origin, normal EOAEs may be obtained from the cochlea, which, although dissociated, is functioning normally. This study examined the status of the cochlea with EOAE in patients with cochlear (Meniere's disease) and neural (surgically proven acoustic neuroma) disease. In patients with presumed cochlear lesions, no emissions were present with mean hearing worse than 40 dB across a frequency range of 0.5 to 4 kHz. Similarly, an EOAE was not present in any of the 26 acoustic neuroma patients studied when the average (0.5 to 4 kHz) hearing was greater than 40 dB. We conclude that dissociation of the cochlea in patients with acoustic neuroma appears to be rare and, in fact, cochlear involvement occurs in most cases. Possible mechanisms responsible for the effect on the cochlea in this group include degenerative changes due to chronic partial obstruction of the blood supply by the tumour, biochemical alterations in the inner ear fluids, loss of efferent control of active mechanical tuning, and hair cell degeneration secondary to neuronal loss in the eighth nerve.

Entities:  

Mesh:

Year:  1995        PMID: 7653257     DOI: 10.3109/00016489509139332

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  8 in total

1.  Dysfunction of the cochlea contributing to hearing loss in acoustic neuromas: an underappreciated entity.

Authors:  Christof Roosli; Fred H Linthicum; Sebahattin Cureoglu; Saumil N Merchant
Journal:  Otol Neurotol       Date:  2012-04       Impact factor: 2.311

2.  Sudden cochlear hearing loss as presenting symptom of arachnoid cyst of the posterior fossa.

Authors:  G Cadoni; S Agostino; M Volante; M S Scipione
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-04       Impact factor: 2.124

3.  A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.

Authors:  Jeffrey R Gehlhausen; Su-Jung Park; Ann E Hickox; Matthew Shew; Karl Staser; Steven D Rhodes; Keshav Menon; Jacquelyn D Lajiness; Muithi Mwanthi; Xianlin Yang; Jin Yuan; Paul Territo; Gary Hutchins; Grzegorz Nalepa; Feng-Chun Yang; Simon J Conway; Michael G Heinz; Anat Stemmer-Rachamimov; Charles W Yates; D Wade Clapp
Journal:  Hum Mol Genet       Date:  2014-08-11       Impact factor: 6.150

4.  Clinical features of vestibular schwannomas in patients who experience hearing improvement after surgery.

Authors:  Michihiro Kohno; Shigeo Sora; Hiroaki Sato; Masanobu Shinogami; Hidehiko Yoneyama
Journal:  Neurosurg Rev       Date:  2014-12-21       Impact factor: 3.042

5.  The clinical characteristics of tinnitus in patients with vestibular schwannoma.

Authors:  David M Baguley; Rachel L Humphriss; Patrick R Axon; David A Moffat
Journal:  Skull Base       Date:  2006-05

6.  Hearing improvement after tumor removal in a vestibular schwannoma patient with severe hearing loss.

Authors:  Y Inoue; K Ogawa; J Kanzaki
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-05-08       Impact factor: 2.503

7.  Change in hearing and tinnitus in conservatively managed vestibular schwannomas.

Authors:  Nicola Quaranta; David M Baguley; David A Moffat
Journal:  Skull Base       Date:  2007-07

8.  Hearing improvement in a growing vestibular schwannoma.

Authors:  Marcos Martinez Del Pero; Simon K W Lloyd; David A Moffat
Journal:  Skull Base       Date:  2009-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.